TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Novo Nordisk Scandinavia AB
Closing information (x1000 SEK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
1,793,809
|
1,166,767
|
936,442 |
Financial expenses |
401
|
86
|
120 |
Earnings before taxes |
71,492
|
51,179
|
28,768 |
EBITDA |
66,530
|
49,993
|
28,984 |
Total assets |
487,581
|
447,401
|
392,246 |
Current assets |
487,323
|
447,033
|
391,769 |
Current liabilities |
319,806
|
304,670
|
287,568 |
Equity capital |
127,342
|
99,589
|
70,064 |
- share capital |
100
![]() |
100
![]() |
100 |
Employees (average) |
110
|
115
|
106 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
26.1%
|
22.3%
|
17.9% |
Turnover per employee |
16,307
|
10,146
|
8,834 |
Profit as a percentage of turnover |
4.0%
|
4.4%
|
3.1% |
Return on assets (ROA) |
14.7%
|
11.5%
|
7.4% |
Current ratio |
152.4%
|
146.7%
|
136.2% |
Return on equity (ROE) |
56.1%
|
51.4%
|
41.1% |
Change turnover |
627,042
|
230,325
|
-32,098 |
Change turnover % |
54%
|
25%
|
-3% |
Chg. No. of employees |
-5
|
9
|
11 |
Chg. No. of employees % |
-4%
|
8%
|
12% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.